General approach of the patient with diffuse parenchymal lung disease

Autor: Mira Avendaño Isabel C

Fragmento

Definition: Multiple disorders characterized by inflammation and fibrotic changes affecting no only the interstitum, but pleura, airways, vessels, and epithelial cells of the alveoli and bronchioles. For this reason, the term Diffuse Parenchymal Lung Disease (DPLD) is considered correct. Generally, both lungs are affected. The clinical presentation can be Acute, Subacute or Chronic. There are identified causes in some cases, being the more common, Conective Tissue disease (CTD), Granulomatous disorderes and Drugs or environmental exposures. There are specific forms of DPLD as well, like Lymphoangiolyomyomatosis (LAM) or Pulmonary Langerhans Cell Hystiosytosis (PLCH), and finally the most important group corresponds to The Idiophatic Interstitial Pneumonias (IIP).

Palabras clave:

2014-08-14   |   258 visitas   |   Evalua este artículo 0 valoraciones

Vol. 1 Núm.1. Enero-Junio 2012 Pags. 5-13 Rev Eviden HUS 2012; 1(I)